Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

BeiGene Ltd
delisted

BeiGene Ltd

BGNE · NASDAQ
BGNE · NASDAQ
184.91
USD1.100.60%

Latest News

    @Reuters
    Reuters

    AbbVie sues rival BeiGene over alleged theft of cancer therapy secrets https://t.co/s5PM7sArdj https://t.co/fmmnx6uJlG

      @Reuters
      Reuters

      US FDA approves BeiGene's esophageal cancer therapy https://t.co/DZo7klTVoA https://t.co/fU1WbbCmw8

        @Reuters
        Reuters

        BeiGene-Novartis gastric cancer drug succeeds in late-stage trial https://t.co/CBngzY9BON https://t.co/NGhzUdYSqv

          @Reuters
          Reuters

          BeiGene-Novartis gastric cancer drug succeeds in late-stage trial https://t.co/N35h1En1Ad https://t.co/O9L6fzc7V8

            @DanZanger
            DanZanger

            $BGNE - Over $50 in gains and we reduced. https://t.co/8eM9a3rl7R

              @breakingmkts
              breakingmkts

              Upgrades $AMCR $AMCR $BGNE $BIIB $CL $CMCSA $LVS $SON $XNCRhttps://t.co/eAzzXndDm3 https://t.co/7wFuoJna8w

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              183.91USD
              187.42USD

              52 Week Range

              126.97USD
              248.16USD

              Market Cap

              20.21BUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US07725L1026

              CUSIP

              07725L102

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -

              Book Value

              226.72

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -8.19

              Wall Street Target Price

              280.92

              EPS Estimate Current Year

              -5.55

              EPS Estimate Next Year

              -0.56

              EPS Estimate Current Quarter

              -1.2

              EPS Estimate Next Quarter

              -1.3

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              23,507,726,336

              Gross Profit TTM

              -511,062,000

              EBITDA

              -5,576,400,384

              Profit Margin

              -25.50%

              Return On Assets TTM

              -9.58%

              Return On Equity TTM

              -23.22%

              Revenue Per Share TTM

              225.239

              Qtly Revenue Growth YOY

              39.50%

              Diluted Eps TTM

              -8.19

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              384

              Price Sales TTM

              0.8597

              Price Book MRQ

              5.6058

              Enterprise Value Revenue

              5

              Enterprise Value EBITDA

              -11

              Peers analysis

              • CSL Ltd
                CSLLYCSL Ltd

                23.21

                1.58%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                305.59

                -2.69%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                749.10

                -2.23%
              • argenx SE
                ARGNFargenx SE

                781.00

                -2.19%
              • UCB SA
                UCBJFUCB SA

                291.41

                -1.73%
              • UCB SA ADR
                UCBJYUCB SA ADR

                141.09

                -1.73%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                430.29

                -1.17%
              • argenx NV ADR
                ARGXargenx NV ADR

                780.25

                -1.01%
              • CSL Limited
                CMXHFCSL Limited

                91.73

                -0.71%
              • BioNTech SE
                BNTXBioNTech SE

                104.83

                -0.69%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is BeiGene Ltd stock price today?

              What is BeiGene Ltd stock ticker?

              Is BGNE stock price going up?

              What is the analyst recommendation for BGNE?

              What is BGNE market cap?

              Does BGNE release financial reports?

              When is BGNE next earnings date?

              What were BGNE Earnings for the last quarter?

              What was BGNE Revenue for the last quarter?

              What was BGNE Net Income for the last quarter?

              Does BGNE pay dividends?

              How many employees does BGNE have?

              What is BGNE EBITDA?

              How to buy BGNE stocks?

              Should I invest in BGNE stock?